Return on Equity (ROE)
Updated 272h ago
Sector Performance
79th percentileCF
27.3%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how efficiently a company generates profit from shareholders’ equity — a 27.3% ROE means the company earns $27.30 for every $100 of equity.
This is well above its sector median of 13.9% and places it in the 78th percentile among peers, indicating superior profitability relative to competitors. Trend data are not available: the year-over-year change is reported as N/A, the quarter-over-quarter change as N/A, and no historical values beyond the current 27.3% are provided. The combination of a strong ROE level with no available trend creates uncertainty — the high profitability is a positive signal, but without knowing whether it is improving or declining, investors cannot gauge momentum. This standalone strength supports a cautious reading but does not contradict the overall NEUTRAL verdict, since the absence of trend data prevents a more decisive positive or negative call.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about CF?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are CF's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master CF's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full CF research report →CF
27.3%
Sector Median
13.8%
Sector Avg
31.4%
How CF's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.